MONTREAL, July 27 /CNW Telbec/ - (TSX-V: BUG - News), Biophage Pharma Inc. (the “Corporation”) reports today its financial results for the second quarter of 2006 ended May 31, 2006. During the quarter, Biophage achieved significant performance milestones in the development and commercialization of its PDS(R) Biosensor, and accepted delivery of the first commercial prototype. Prior to a full product launch, the Corporation has initiated Phase 4 of its development program, which will include extensive product testing in the market place and beta testing at various independent laboratories.
